Cabio Biotech Wuhan Co Ltd (688089)

Currency in CNY
27.90
-0.13(-0.46%)
Closed·
688089 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
688089 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
27.6328.15
52 wk Range
14.0630.12
Key Statistics
Bid/Ask
27.89 / 27.90
Prev. Close
28.03
Open
28.03
Day's Range
27.63-28.15
52 wk Range
14.06-30.12
Volume
2.78M
Average Volume (3m)
4.38M
1-Year Change
77.71%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688089 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
28.00
Upside
+0.36%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Cabio Biotech Wuhan Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Cabio Biotech Wuhan Co Ltd Company Profile

Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields. The company was founded in 1999 and is based in Wuhan, the People’s Republic of China.

Employees
565
Market
China

Compare 688089 to Peers and Sector

Metrics to compare
688089
Peers
Sector
Relationship
P/E Ratio
32.4x32.8x2.2x
PEG Ratio
0.660.350.00
Price/Book
2.9x1.8x1.6x
Price / LTM Sales
7.9x1.8x1.3x
Upside (Analyst Target)
0.4%4.9%20.0%
Fair Value Upside
Unlock4.1%2.4%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 28.00
(+0.36% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.87%
Dividend Yield
0.72%
Industry Median 2.33%
Annualised payout
0.20
Paid annually
5-Years Growth
-10.95%
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.27 / --
Revenue / Forecast
155.97M / --
EPS Revisions
Last 90 days

688089 Income Statement

FAQ

What Stock Exchange Does Cabio Biotech Wuhan Co Trade On?

Cabio Biotech Wuhan Co is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Cabio Biotech Wuhan Co?

The stock symbol for Cabio Biotech Wuhan Co is "688089."

What Is the Cabio Biotech Wuhan Co Market Cap?

As of today, Cabio Biotech Wuhan Co market cap is 4.70B.

What Is Cabio Biotech Wuhan Co's Earnings Per Share (TTM)?

The Cabio Biotech Wuhan Co EPS (TTM) is 0.87.

When Is the Next Cabio Biotech Wuhan Co Earnings Date?

Cabio Biotech Wuhan Co will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is 688089 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Cabio Biotech Wuhan Co Stock Split?

Cabio Biotech Wuhan Co has split 1 times.

How Many Employees Does Cabio Biotech Wuhan Co Have?

Cabio Biotech Wuhan Co has 565 employees.

What is the current trading status of Cabio Biotech Wuhan Co (688089)?

As of 09 Aug 2025, Cabio Biotech Wuhan Co (688089) is trading at a price of 27.90, with a previous close of 28.03. The stock has fluctuated within a day range of 27.63 to 28.15, while its 52-week range spans from 14.06 to 30.12.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.